Thomas Gayner - Markel Group Inc.
Holding/activity history for CVS Health Corp. (CVS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2024 Q2 | 47,000 | 0.03 | Reduce 85.84% | 0.22 | $59.06 | $2,775,820 | SEC |
| 2024 Q1 | 332,000 | 0.26 | $79.76 | $26,480,320 | SEC | ||
| 2023 Q4 | 332,000 | 0.29 | $78.96 | $26,214,720 | SEC | ||
| 2023 Q3 | 332,000 | 0.28 | $69.82 | $23,180,240 | SEC | ||
| 2023 Q2 | 332,000 | 0.27 | $69.13 | $22,951,160 | SEC | ||
| 2023 Q1 | 332,000 | 0.32 | $74.31 | $24,670,920 | SEC | ||
| 2022 Q4 | 332,000 | 0.42 | $93.19 | $30,939,080 | SEC | ||
| 2022 Q3 | 332,000 | 0.47 | $95.37 | $31,662,000 | SEC | ||
| 2022 Q2 | 332,000 | 0.44 | $92.66 | $30,763,000 | SEC | ||
| 2022 Q1 | 332,000 | 0.40 | $101.21 | $33,601,000 | SEC | ||
| 2021 Q4 | 332,000 | 0.40 | $103.16 | $34,249,000 | SEC | ||
| 2021 Q3 | 332,000 | 0.36 | $84.86 | $28,174,000 | SEC | ||
| 2021 Q2 | 332,000 | 0.35 | $83.44 | $27,702,000 | SEC | ||
| 2021 Q1 | 332,000 | 0.35 | $75.23 | $24,976,000 | SEC | ||
| 2020 Q4 | 332,000 | 0.34 | $68.30 | $22,676,000 | SEC | ||
| 2020 Q3 | 332,000 | 0.33 | $58.40 | $19,389,000 | SEC | ||
| 2020 Q2 | 332,000 | 0.40 | $64.97 | $21,570,000 | SEC | ||
| 2020 Q1 | 332,000 | 0.37 | $59.33 | $19,698,000 | SEC | ||
| 2019 Q4 | 332,000 | 0.35 | Add 2.79% | <0.01 | $74.29 | $24,665,000 | SEC |
| 2019 Q3 | 323,000 | 0.31 | Add 17.45% | 0.05 | $63.07 | $20,371,000 | SEC |
| 2019 Q2 | 275,000 | 0.23 | $54.49 | $14,985,000 | SEC | ||
| 2019 Q1 | 275,000 | 0.25 | $53.93 | $14,831,000 | SEC | ||
| 2018 Q4 | 275,000 | 0.35 | $65.52 | $18,018,000 | SEC | ||
| 2018 Q3 | 275,000 | 0.37 | $78.72 | $21,648,000 | SEC | ||
| 2018 Q2 | 275,000 | 0.33 | $64.35 | $17,696,000 | SEC | ||
| 2018 Q1 | 275,000 | 0.33 | Add 3.00% | <0.01 | $62.21 | $17,108,000 | SEC |
| 2017 Q4 | 267,000 | 0.37 | $72.50 | $19,357,000 | SEC | ||
| 2017 Q3 | 267,000 | 0.44 | $81.32 | $21,712,000 | SEC | ||
| 2017 Q2 | 267,000 | 0.47 | Add 1.14% | <0.01 | $80.46 | $21,483,000 | SEC |
| 2017 Q1 | 264,000 | 0.47 | Add 6.45% | 0.03 | $78.50 | $20,724,000 | SEC |
| 2016 Q4 | 248,000 | 0.48 | Add 0.40% | <0.01 | $78.91 | $19,570,000 | SEC |
| 2016 Q3 | 247,000 | 0.57 | $88.99 | $21,981,000 | SEC | ||
| 2016 Q2 | 247,000 | 0.63 | $95.74 | $23,648,000 | SEC | ||
| 2016 Q1 | 247,000 | 0.70 | $103.73 | $25,621,000 | SEC | ||
| 2015 Q4 | 247,000 | 0.66 | $97.77 | $24,149,000 | SEC | ||
| 2015 Q3 | 247,000 | 0.64 | $96.48 | $23,831,000 | SEC | ||
| 2015 Q2 | 247,000 | 0.66 | Add 0.82% | <0.01 | $104.88 | $25,905,000 | SEC |
| 2015 Q1 | 245,000 | 0.65 | Add 5.60% | 0.03 | $103.21 | $25,286,000 | SEC |
| 2014 Q4 | 232,000 | 0.57 | Add 6.42% | 0.03 | $96.31 | $22,344,000 | SEC |
| 2014 Q3 | 218,000 | 0.51 | Add 10.66% | 0.05 | $79.59 | $17,351,000 | SEC |
| 2014 Q2 | 197,000 | 0.44 | Add 105.21% | 0.23 | $75.37 | $14,848,000 | SEC |
| 2014 Q1 | 96,000 | 0.23 | Buy | 0.23 | $74.86 | $7,187,000 | SEC |